GHRS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
GH Research PLC (GHRS) is not a strong buy for a beginner, long-term investor at this moment. The stock lacks clear positive momentum, and the financials indicate no revenue growth with continued losses. While analysts are optimistic about the long-term potential of its product pipeline, the current technical and options data suggest a neutral to bearish sentiment. Given the user's impatience and unwillingness to wait for optimal entry points, holding off on buying is recommended for now.
The technical indicators suggest a neutral to bearish trend. The MACD histogram is negative and contracting, the RSI is neutral at 42.456, and moving averages are converging. The stock is trading below the pivot level of 15.112, with support at 14.014 and resistance at 16.211. These indicators do not signal a strong buying opportunity.
Analysts have raised the price target to $40 from $33, citing optimism about the long-term sales potential of GH
Hedge funds have significantly increased their buying activity, up 735.47% over the last quarter.
The company has no revenue and continues to report significant losses (-$14.02M net income in Q3 2025).
Technical indicators and options data suggest bearish sentiment.
No recent news or congress trading data to support a positive outlook.
In Q3 2025, the company reported no revenue growth (0% YoY) and a net income loss of -$14.02M, which improved by 15.73% YoY. EPS remained negative at -0.23. The company has no gross margin due to the lack of revenue.
RBC Capital raised the price target to $40 from $33 and maintained an Outperform rating, citing optimism about the long-term sales potential of GH001. However, this is based on future expectations rather than current performance.
